Results 61 to 70 of about 142,321 (206)
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma
Background: Hodkin s lymphoma is one of the most frequent lymphoma in western world. Despite an overall good prognosis some patients suffer relapsing tumors which are difficult to cure.
Renné Christoph +5 more
core +1 more source
Malignant lymphomas (ML) and HIV/AIDS Infection in Tanzania. [PDF]
\ud HIV infection is reported to be associated with some malignant lymphomas (ML) so called AIDS-related lymphomas (ARL), with an aggressive behavior and poor prognosis.
Mwakigonja Amos R +5 more
core +1 more source
BACKGROUND: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our task is to present the clinicopathologic correlations and therapeutic results for adult T-cell
Ullrich F +64 more
core +1 more source
Background: Primary cutaneous T-cell lymphomas (CTCL) are heterogenous extranodal non-Hodgkin lymphomas including a few distinct and provisional entities.
Win, Khin Than;Liau, Jau-Yu;Chen, Bo-Jung;Takata, Katsuyoshi;Chen, Chiao-Yun;Li, Chi-Cheng;Hsiao, Cheng-Hsiang;Chuang, Shih-Sung +1 more
core +1 more source
ESMO Consensus conferences:guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma [PDF]
To complement the existing treatment guidelines for all tumour types, ESMO organizes consensus conferences to focus on specific issues in each type of tumour.
Zinzani P +49 more
core +1 more source
The function and origin of the CD4+ T cell in the classical Hodgkin lymphoma microenvironment
PhDClassical Hodgkin lymphoma (CHL) is a germinal centre B cell malignancy where the bulk of the tumour comprises a non-clonal immune infiltrate enriched for CD4+ T cells.
Greaves, Paul
core
Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma
Background: The prognosis of T-cell lymphoma is poor. To explore the addition of the monoclonal antibody alemtuzumab, we studied the efficacy and tolerability of an intensified alemtuzumab-chemotherapy combination for aggressive T-cell lymphoma in a ...
Luten, M. +13 more
core +1 more source
In the present study the clinicopathologic and immunophenotypic features of 82 patients with a CD30(-) peripheral T-cell lymphoma, unspecified, presenting in the skin were evaluated.
Meijer, CJLM +8 more
core +1 more source
An update on the management of peripheral T-cell lymphoma and emerging treatment options
Adrienne A Phillips1, Colette Owens2, Sangmin Lee1, Govind Bhagat31Division of Medical Oncology, Department of Medicine, 2Division of General Medicine, Department of Medicine, 3Department of Pathology and Cell Biology, Columbia University Medical Center ...
Lee S, Bhagat G, Owens C, Phillips AA
core
Nodal follicular helper T-cell-derived lymphoproliferations (specifically the less common peripheral T-cell lymphomas of follicular type) exhibit a spectrum of histologic features that may mimic reactive hyperplasia or Hodgkin lymphoma.
Gurbuxani, Sandeep +17 more
core +1 more source

